Clinical and Translational Research Unit (CTRU) & Spectrum Biobank — Palo Alto, California

Clinical and Translational Research Unit (CTRU) & Spectrum Biobank is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical and Translational Research Unit (CTRU) & Spectrum Biobank has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19.

Sponsors: BioNTech SE.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical and Translational Research Unit (CTRU) & Spectrum Biobank?

Clinical and Translational Research Unit (CTRU) & Spectrum Biobank has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical and Translational Research Unit (CTRU) & Spectrum Biobank conducted?

Clinical and Translational Research Unit (CTRU) & Spectrum Biobank has 1 clinical trials on record, with 1 currently active. Their work covers SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19.

Is Clinical and Translational Research Unit (CTRU) & Spectrum Biobank accredited by Crixeo Health?

Clinical and Translational Research Unit (CTRU) & Spectrum Biobank has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical and Translational Research Unit (CTRU) & Spectrum Biobank?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.